WRF
NVAX icon

Waddell & Reed Financial’s Novavax NVAX Stock Holding History

Waddell & Reed Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$22.2M Buy
122,710
+35,903
+41% +$7.15M 0.05% 350
2020
Q4 		$9.68M Buy
86,807
+127
+0.1% +$13.5K 0.02% 404
2020
Q3 		$9.39M Buy
86,680
+46,333
+115% +$5.64M 0.02% 381
2020
Q2 		$3.36M Buy
+40,347
New +$1.54M 0.01% 432

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Waddell & Reed Financial's NVAX Position: Q1 2021 in Review

Waddell & Reed Financial increased its Novavax (NVAX) stake by 41% in Q1 2021, buying an estimated $7.15M and bringing the position to 122,710 shares worth $22.2M. The position accounts for 0.05% of the portfolio, ranked #350.

Waddell & Reed Financial first reported a position in NVAX in Q2 2020 and has held it in 4 quarters since. 389 funds tracked by Wall St. Rank hold NVAX as of Q1 2021.

  • Waddell & Reed Financial held 122,710 shares of Novavax worth $22.2M as of Q1 2021.
  • Waddell & Reed Financial bought 35,903 Novavax shares in Q1 2021, an estimated $7.15M.
  • Novavax made up 0.05% of Waddell & Reed Financial's portfolio in Q1 2021, its #350 holding.
  • Waddell & Reed Financial first reported a position in Novavax in Q2 2020 and has held it in 4 quarters since.
  • 389 funds tracked by Wall St. Rank held Novavax as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.